Trial

TMC207-TiDP13-208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Patients With MDR-TB (Phase 2)

Study Director
Start Date
5 / 2007
Trial Phase
Trial Status
published
Current Enrollment
208
Target Enrollment
Overview
Compound Associations
Bedaquiline